Home LiteratureArticle Details
PMID: 23758743 Published · epublish English Journal Article

SHANK3 haploinsufficiency: a "common" but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders.

Molecular autism ·Vol. 4 ·No. 1 ·2013-06-11 ·Pages 17

Betancur C, Buxbaum JD

Abstract

Autism spectrum disorders (ASD) are etiologically heterogeneous, with hundreds of rare, highly penetrant mutations and genomic imbalances involved, each contributing to a very small fraction of cases. In this issue of Molecular Autism, Soorya and colleagues evaluated 32 patients with Phelan-McDermid syndrome, caused by either deletion of 22q13.33 or SHANK3 mutations, using gold-standard diagnostic assessments and showed that 84% met criteria for ASD, including 75% meeting criteria for autism. This study and prior studies demonstrate that this syndrome appears to be one of the more penetrant causes of ASD. In this companion review, we show that in samples ascertained for ASD, SHANK3 haploinsufficiency is one of the more prevalent monogenic causes of ASD, explaining at least 0.5% of cases. We note that SHANK3 haploinsufficiency remains underdiagnosed in ASD and developmental delay, although with the increasingly widespread use of chromosomal microarray analysis and targeted sequencing of SHANK3, the number of cases is bound to rise.

Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Betancur Catalina
INSERM U952, Paris, France. [email protected].
Buxbaum Joseph D
References (23)
23 references, click to expand
  1. Global increases in both common and rare copy number load associated with autism.
    Hum Mol Genet. 2013 Jul 15;22(14):2870-80 PMID: 23535821
  2. Application of custom-designed oligonucleotide array CGH in 145 patients with autistic spectrum disorders.
    Eur J Hum Genet. 2013 Jun;21(6):620-5 PMID: 23032108
  3. Gene-network analysis identifies susceptibility genes related to glycobiology in autism.
    PLoS One. 2009 May 28;4(5):e5324 PMID: 19492091
  4. Novel de novo SHANK3 mutation in autistic patients.
    Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):421-4 PMID: 18615476
  5. Copy number variation characteristics in subpopulations of patients with autism spectrum disorders.
    Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):115-24 PMID: 21302340
  6. The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome).
    Mol Syndromol. 2012 Apr;2(3-5):186-201 PMID: 22670140
  7. A copy number variation morbidity map of developmental delay.
    Nat Genet. 2011 Aug 14;43(9):838-46 PMID: 21841781
  8. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders.
    Hum Mol Genet. 2011 Sep 1;20(17):3366-75 PMID: 21624971
  9. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.
    Brain Res. 2011 Mar 22;1380:42-77 PMID: 21129364
  10. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism.
    Neuron. 2011 Jun 9;70(5):863-85 PMID: 21658581
  11. Contribution of SHANK3 mutations to autism spectrum disorder.
    Am J Hum Genet. 2007 Dec;81(6):1289-97 PMID: 17999366
  12. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation.
    Arch Gen Psychiatry. 2009 Sep;66(9):947-56 PMID: 19736351
  13. Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders.
    Genet Med. 2010 Nov;12(11):694-702 PMID: 20808228
  14. Functional impact of global rare copy number variation in autism spectrum disorders.
    Nature. 2010 Jul 15;466(7304):368-72 PMID: 20531469
  15. Array comparative genomic hybridization findings in a cohort referred for an autism evaluation.
    J Child Neurol. 2010 Dec;25(12):1498-503 PMID: 20729506
  16. Association between microdeletion and microduplication at 16p11.2 and autism.
    N Engl J Med. 2008 Feb 14;358(7):667-75 PMID: 18184952
  17. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.
    Am J Hum Genet. 2011 Mar 11;88(3):306-16 PMID: 21376300
  18. High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability.
    PLoS One. 2012;7(4):e34739 PMID: 22509352
  19. Phenomic determinants of genomic variation in autism spectrum disorders.
    J Med Genet. 2009 Oct;46(10):680-8 PMID: 19625284
  20. Clinical genetic testing for patients with autism spectrum disorders.
    Pediatrics. 2010 Apr;125(4):e727-35 PMID: 20231187
  21. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.
    Nat Genet. 2007 Jan;39(1):25-7 PMID: 17173049
  22. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders.
    Eur J Hum Genet. 2013 Mar;21(3):310-6 PMID: 22892527
  23. Strong association of de novo copy number mutations with autism.
    Science. 2007 Apr 20;316(5823):445-9 PMID: 17363630
Article Info
Journal
Molecular autism
Abbr.
Mol Autism
ISSN
2040-2392
Published
2013-06-11
Epub
2013-00-11
Pages
17
Language
English
Region
England
NLM ID
101534222
PMCID
PMC3695795
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]